Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Mar;6(1):48-50.
doi: 10.1007/s12105-011-0288-5. Epub 2011 Aug 30.

Palate hyperpigmentation caused by prolonged use of the anti-malarial chloroquine

Affiliations
Case Reports

Palate hyperpigmentation caused by prolonged use of the anti-malarial chloroquine

Mário Rodrigues de Melo Filho et al. Head Neck Pathol. 2012 Mar.

Abstract

The side-effects of many drugs manifest in the oral mucosa. The anti-malarial agent chloroquine diphosphate, which is also used to treat immunological, dermatological, and rheumatological disorders, usually causes pigmentary changes in the oral mucosa. This report presents a case of palate pigmentation related to the prolonged use of chloroquine diphosphate caused by the deposition of drug metabolites in the mucosa. Healthcare professionals must be aware of these drugs and their adverse effects in order to make the correct diagnosis, decide on the optimal treatment for the condition, or refer the patient to an appropriate specialist.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Intraoral examination revealed a large 4 cm area of black to gray pigmentation with irregular borders involving the hard palate
Fig. 2
Fig. 2
Gross photograph of the tissue removed from the hard palate by incisional biopsy for histopathologic analysis showing marked discoloration
Fig. 3
Fig. 3
The basophilic granules are chloroquine metabolites deposited in the mucosal tissue of the hard palate (arrows) (hematoxylin-eosin, ×400)

References

    1. Porter SR, Scully C. Adverse drug reactions in the mouth. Clin Dermatol. 2000;18:525–532. doi: 10.1016/S0738-081X(00)00143-7. - DOI - PubMed
    1. Arana LA, Arana J, Hasimoto AR, et al. Tomografia de coerência óptica na avaliação da camada de fibras nervosas peripapilar nos usuários de cloroquina. Arq Bras Oftalmol. 2010;73:28–32. doi: 10.1590/S0004-27492010000100005. - DOI - PubMed
    1. Kleinegger CL, Hammond HL, Finkelstein MW. Oral mucosal hyperpigmentation secondary to antimalarial drug therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:189–194. doi: 10.1067/moe.2000.106340. - DOI - PubMed
    1. Martin TJM, Sharp I. Oral mucosal pigmentation secondary to treatment with mepacrine, with sparing of the denture bearing área. Br J Oral Maxillofac Surg. 2004;42:351–353. doi: 10.1016/j.bjoms.2004.02.027. - DOI - PubMed
    1. Gouveia EB, Morales MAS, Gouveia GB, et al. Toxicidade ocular por derivados da 4-aminoquinolona. Arq Bras Oftalmol. 2007;70:1046–1051. doi: 10.1590/S0004-27492007000600033. - DOI - PubMed

Publication types

LinkOut - more resources